Hao Hu

Prof. Dr. Hao Hu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XSXiaowen Su
Xiaowen Su
TLTiantian Lai
Tiantian Lai
YTYue Tao
Yue Tao
YZYong Zhang
Yong Zhang
CZChangyong Zhao
Changyong Zhao
HHHao Hu
Hao Hu
Recent studies have shown that amphoteric regulatory protein (AREG), a member of the epidermal growth factor (EGF) family, is expressed in many cancers and is an independent prognostic indicator for patients with pancreatic cancer, but whether AREG is regulated at the epigenetic level to promote the development of pancreatic cancer (PC) has not been elucidated. Our results support the notion that AREG is overexpressed in pancreatic cancer tissues and cell lines. Functionally, the deletion of AREG impedes pancreatic cancer (PC) cell proliferation, migration, and invasion. In addition, we identified and validated that methyltransferase-like 3 (METTL3) induced the m6A modification on AREG and facilitated the stability of AREG mRNA after sequencing. Additionally, we obtained experimental evidence that miR-33a-3p targets and inhibits METTL3 from taking action, as predicted by using the miRDB and RNAinter. Remediation experiments showed that miR-33a-3p inhibits PC progression through METTL3. In summary, this research reveals that miR-33a-3p inhibits m6A-induced stabilization of AREG by targeting METTL3, which plays a key role in the aggressive progression of PC. AREG could be a potential target for PC treatment.

22 August 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
LWLeisheng Wang
Leisheng Wang
SXShiwei Xu
Shiwei Xu
MZMengzhen Zhou
Mengzhen Zhou
HHHao Hu
Hao Hu
JLJinyou Li
Jinyou Li
Fatty acid metabolism is a complex biochemical process, including the production, breakdown and application of fatty acids. Not only is it an important component of lipid metabolism, fatty acid metabolism is also connected to the energy metabolism pathways of cells and plays a vital role in maintaining the energy balance of organisms. Diacylglycerol-O-acyltransferase 1 (DGAT1) and Diacylglycerol-O-acyltransferase 2 (DGAT2) are key components in regulating lipid metabolism, which provide energy for cell proliferation and growth. Recent studies have shown that DGAT1 and DGAT2 influence tumor progression through fatty acid metabolism in cancer. Although DGAT1 and DGAT2 have similar names, they differ significantly in various aspects and play distinct roles in individual tumors. A comparative analysis of the physiological roles of these enzymes and their differential expressions in different types of tumors will enhance our understanding of their unique characteristics. This article summarizes the characteristics of tumor fatty acid metabolism and explains how DGAT1 and DGAT2 specifically promote tumor progression. In addition, this review discusses the potential of lipid-lowering drugs in tumor treatment, providing a new perspective on targeting fatty acid metabolism to inhibit tumor progression in the future, while emphasizing the importance of DGAT1 and DGAT2 as potential targets for tumor treatment.

1 January 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HHHao Hu
Hao Hu
YHYuan He
Yuan He
YWYandong Wang
Yandong Wang
WCWuqiang Chen
Wuqiang Chen
BHBenshun Hu
Benshun Hu
YGYuanLong Gu
YuanLong Gu

1 October 2021 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
HHHao Hu
Hao Hu
SZShuo Zhang
Shuo Zhang
SXShuming Xiong
Shuming Xiong
BHBenshun Hu
Benshun Hu
YHYouzhao He
Youzhao He
YGYuanlong Gu
Yuanlong Gu
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma Hao Hu, Shuo Zhang, Shuming Xiong, Benshun Hu, Youzhao He, Yuanlong Gu

2 July 2024 in European Journal of Oncology Nursing
Verified
Journal Article
Open access
YTYue Tao
Yue Tao
YZYan Zhang
Yan Zhang
JCJie Chen
Jie Chen
LWLeisheng Wang
Leisheng Wang
NZNa Zhu
Na Zhu
HHHao Hu
Hao Hu
To evaluate the effectiveness of the PRECEDE-PROCEED model (PPM) in helping patients with liver cancer be aware of their knowledge, skills, and abilities in self-oral health behaviors and improve their oral health status. This is a quasi-experimental study of 90 patients with liver cancer assigned to an oral health education or a control group. The intervention group was educated with the PRECEDE-PROCEED model. A brief oral scale and the knowledge, attitude, and practice oral health questionnaire were employed to measure the oral health status and cognitive behavioral ability to seek oral health in patients. Among 102 eligible patients, 90 (88.23%) agreed to participate in the present study and were divided to intervention (n = 45) or control (n = 45) groups. After the intervention and one month after discharge, the oral health scores of patients in the Intervention group were lower than those of the control group (P < 0.05). In addition, after the intervention and one month after discharge, the patients in the test group had higher scores on knowledge, beliefs, and behaviors of oral health than the control group (P < 0.05). One month after discharge, the mean knowledge and skills scores were significantly higher in the intervention group than in the control group. Our findings suggest that oral health education may be a useful health intervention for patients with liver cancer. It may also improve the knowledge and beliefs of liver cancer patients seeking oral health. Larger long-term investigations are necessary to provide more support for these preliminary conclusions.

19 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YTYue Tao
Yue Tao
LWLeisheng Wang
Leisheng Wang
ECEnhong Chen
Enhong Chen
SZShuo Zhang
Shuo Zhang
DYDongjie Yang
Dongjie Yang
HHHao Hu
Hao Hu
Primary liver cancer (PLC) is a prevalent tumor globally, ranking third in cancer-related mortality. The role of N4-acetylcysteine (ac4C) and N-acetyltransferase 10 (NAT10) in hepatocellular carcinoma (HCC) progression, migration, and invasion requires further elucidation. High NAT10 expression correlated with poor prognosis in HCC patients. Knockdown of NAT10 hindered HCC cell proliferation. AcRIP-seq screening revealed DDIAS as a significant downstream target of NAT10. Decreased NAT10 levels reduced DDIAS mRNA stability, leading to decreased proliferation, migration, and invasion of HCC cells upon DDIAS knockdown. Ectopic expression of DDIAS counteracted the effects of NAT10 knockdown by modulating the PI3K/AKT pathway. NAT10 was found to be elevated in HCC tissues compared to normal tissues, promoting HCC progression and correlating with shorter overall survival in patients. Mechanistically, NAT10 regulated HCC progression through the ac4C–DDIAS–PI3K-AKT axis.